NCT07029802 Development of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury
| NCT ID | NCT07029802 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Spinal Cord Injuries |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-11-18 |
| Primary Completion | 2027-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2024-11-18 with a primary completion date of 2027-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is twofold: (1) Develop a new evaluation scale for mental body representations (MBR, i.e., body awareness and visuospatial body maps) for adults with spinal cord injury (SCI) with and without neuropathic pain. (2) Assess the psychometric properties of usability, reliability, and validity of the new evaluation scale This is a cross-sectional observational study design. For Aim 1, this study will involve initial item generation for a novel MBR evaluation scale for SCI through email communication, and individual interviews proctored remotely through Zoom, or, if preferred by the participant, in-person. For Aim 2, the study will include a Zoom call for consenting and questionnaires, as well as an in-person visit where participants will be tested with the new SCI-BodyMap evaluation scale, and a questionnaire asking about the usability and satisfaction of the new evaluation scale.
Eligibility Criteria
Inclusion Criteria: Control group * Uninjured adults (from the contact list with the Brain Body Mind lab or through fliers or StudyFinder) * 18+ years old adults SCI group * 18+ years old, participants with an incomplete or complete SCI of ≥ 1 year * medically stable * able to read and understand English * having access to the internet/iPad/computer/phone and willing to come in for an in-person testing at the University of Minnesota. Exclusion Criteria: SCI group * Uncontrolled seizure disorder; * cognitive impairment and/or communicative disability (e.g., due to brain injury) preventing them from following directions or from learning; * ventilator dependency; * major medical complications; * pressure ulcers hindering prolonged sitting or lying down.
Contact & Investigator
Ann Van de Winckel
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT07029802 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07029802 currently recruiting?
Yes, NCT07029802 is actively recruiting participants. Contact the research team at carpe749@umn.edu for enrollment information.
Where is the NCT07029802 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT07029802 clinical trial?
NCT07029802 is sponsored by University of Minnesota. The principal investigator is Ann Van de Winckel at University of Minnesota. The trial plans to enroll 80 participants.